Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine DHCPL 04/07/2016 Recommendations on the use of codeine-containing products for treatment of pain and relief of cough and cold in children and adolescents
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Elixir, Codeine Phosphate 10 mg/5 mL + Pseudoephedrine HCl 30 mg/5 mL + Triprolidine HCl 1.25 mg/5 mL National University Hospital
ORAL Select a brand starting with the letter: B F BEACTAFED CO SYRUP [SIN03140P] FEDAC COMPOUND LINCTUS [SIN03195P]